SECOND AMENDMENT TO TO STOCK PURCHASE AGREEMENTTo Stock Purchase Agreement • March 26th, 2009 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
This SECOND AMENDMENT TO STOCK PURCHASE AGREEMENT (this “Amendment”) is entered into as of this March 10, 2009, by and among Interleukin Genetics, Inc., a Delaware corporation (the “Company”), and Pyxis Innovations Inc., a Delaware corporation (“Pyxis”). Unless otherwise defined in this Amendment, capitalized terms used herein shall have the respective meanings ascribed thereto in the Stock Purchase Agreement (defined below).
